• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Rapid Micro Biosystems - Articles and news items

RMMs & Environmental Monitoring Supplement 2013 - 100

RMMs & Environmental Monitoring: In-depth focus 2013

Issue 4 2013, Microbiology / RMMs, Supplements / 21 August 2013 / Emanuele Selvaggio (Pfizer), Chris Delaney (Noonan Services Group)

The rapid microbiological methods revolution.
Controlling contamination in the pharmaceutical industry.
Rapid Micro Methods Roundtable.

Rapid Micro Biosystems Logo

Rapid Micro Biosystems secures $32.6 million in series B financing

News, Supplier news / 26 June 2013 / Rapid Micro Biosystems

Rapid Micro Biosystems announced that it has raised $32.6 million in series B financing…

Quality by Design (QbD) approach to method development

Rapid Method Development and Quality Regulatory Submissions – Combining UPLC, Quality-by-Design (QbD) and Software-Guided Validation

Industry news, Webinars / 8 April 2013 / Waters

During this webinar learn from industry experts some practices to help better manage the investigation process and how to design processes to minimize unnecessary excursions…

managing microbial excursions

Best practices in managing microbial excursions and managing out of specification events

Industry news, Webinars / 8 April 2013 / Rapid Micro Biosystems

This pharma webinar demonstrates best practices to help better manage the investigation process and how to design processes to minimize unnecessary excursions.

Microbial-testing

Accelerating and Automated Rapid Microbial Testing

Industry news, Webinars / 17 October 2012 / Rapid Micro Biosystems

Experts in this pharma webinar demonstrate how rapid technologies, like the Growth Direct™ System can have an impact on microbial quality control and ultimately manufacturing.

Rapid Micro Biosystems Logo

Rapid Micro Biosystems announces the 2013 availability of Growth Direct™ Systems

News, Supplier news / 16 April 2012 / Rapid Micro Biosystems

New applications improve the efficiency of microbial quality control processes…

Under the microscope: Steve Delity

Issue 4 2011 / 31 August 2011 / Steve Delity, CEO, Rapid Micro Biosystems

Rapid Micro Biosystems is a privately owned, venture backed company with headquarters in Bedford, Massachusetts. Since launching its GrowthDirect™ System in 2008, the company has now moved into Europe with the opening of its new demo centre in Darmstadt, Germany in June 2011. So, how does CEO Steve Delity view the current situation in the pharmaceutical industry? “The power of pharmaceutical research and development is so massive that there will always be blockbusters, but will we see the prevalence, the frequency, the number of blockbusters we’ve had in the past? It’s a more efficient deployment of resources to take known drugs and look at whether it’s possible to increase their efficacy or decrease the side effects. The hunt for the next big blockbuster will always be there, but you can spend a lot of money and come up with nothing in the end, which is a huge risk.”

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +